Seattle's life science market entered the second half of 2026 with the lowest vacancy of any major West Coast hub and no space...
ByThe RegistrySeptember 14, 2026Genentech will invest approximately $750 million to double its Hillsboro, Oregon manufacturing campus with a new device fill-finish facility, adding 250 jobs as...
ByThe RegistryAugust 21, 2026A biomanufacturing facility that Pfizer abandoned two years into a $500 million build-out has changed hands for a fraction of that investment, landing...
ByThe RegistryAugust 13, 2026Alexandria Real Estate Equities singled out Seattle as one of three markets where advanced technology tenants are absorbing buildings the REIT once planned...
ByThe RegistryAugust 5, 2026Magnolia Medical Technologies, the Seattle diagnostics company whose Steripath device reduces false-positive blood culture results in sepsis testing, has committed to 9,751 square...
ByThe RegistryJuly 14, 2026Oncology company Immunome has added 13,346 square feet at 11804 North Creek Parkway, expanding within the same Bothell campus where it established its...
ByThe RegistryJuly 13, 2026Medical device giant Zimmer Biomet has leased 11,329 square feet in Seattle, taking an entire freestanding flex building that had sat on the...
ByThe RegistryJuly 13, 2026Seattle’s life sciences vacancy rate surged 540 basis points year over year to 19 percent in the second quarter as new lab space...
ByThe RegistryJuly 9, 2026A onetime evangelical sanctuary on Monte Villa Parkway has been gutted and rebuilt into one of the few dedicated cryobiology research labs in...
ByThe RegistryJune 25, 2026A new BSI executive brief argues that the greater Seattle region’s overlapping environmental, workforce and climate regulations have raised the operational bar for...
ByThe RegistryJune 24, 2026The U.S. life sciences real estate market has finally bottomed out after four years of turbulence, according to JLL’s new national lab report,...
ByThe RegistryJune 12, 2026Eli Lilly’s $1.5 billion cash deal for Bothell-based Curevo Vaccine is the kind of validating, capital-attracting exit Puget Sound’s life sciences cluster has...
ByThe RegistryMay 28, 2026